We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov Menu

Arteriovenous Fistula Tissue Bank

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified July 2010 by University of Nebraska.
Recruitment status was:  Recruiting
ClinicalTrials.gov Identifier:
First Posted: February 4, 2009
Last Update Posted: July 16, 2010
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
University of Nebraska
This project will bank sera, DNA and vascular specimens from patients undergoing arteriovenous fistula creation and revision

Condition Intervention
Kidney Failure, Chronic Other: Biologic specimens

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: Arteriovenous Fistula Tissue Bank

Resource links provided by NLM:

Further study details as provided by University of Nebraska:

Biospecimen Retention:   Samples With DNA
Serum, Whole Blood, Tissue

Estimated Enrollment: 50
Study Start Date: February 2009
Estimated Primary Completion Date: November 2011 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
Arteriovenous Fistula Other: Biologic specimens
Banking of serum, DNA and tissue


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   19 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Patients will be eligible if they are 19 years of age or greater and have placement of an arteriovenous fistula planned witin 30 days.

Inclusion Criteria:

  • Age 19 years of age or greater
  • Arteriovenous fistula placement for hemodialysis access scheduled within 30 days

Exclusion Criteria:

  • Incompetent to provide informed consent
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00836862

United States, Nebraska
University of Nebraska Medical Center/The Nebraska Medical Center Recruiting
Omaha, Nebraska, United States, 68105
Contact: LuAnn Larson, RN, BSN    402-559-8555    llarson@unmc.edu   
Principal Investigator: Troy J Plumb, MD         
Sponsors and Collaborators
University of Nebraska
  More Information

Responsible Party: Troy J. Plumb, MD, University of Nebraska Medical Center
ClinicalTrials.gov Identifier: NCT00836862     History of Changes
Other Study ID Numbers: 482-08-EP
First Submitted: February 3, 2009
First Posted: February 4, 2009
Last Update Posted: July 16, 2010
Last Verified: July 2010

Keywords provided by University of Nebraska:
Vascular access
Arteriovenous fistula

Additional relevant MeSH terms:
Renal Insufficiency
Kidney Failure, Chronic
Arteriovenous Fistula
Pathological Conditions, Anatomical
Kidney Diseases
Urologic Diseases
Renal Insufficiency, Chronic
Arteriovenous Malformations
Vascular Malformations
Cardiovascular Abnormalities
Cardiovascular Diseases
Vascular Fistula
Vascular Diseases
Congenital Abnormalities